Keeping Obesity and Metabolic Syndrome at Bay with Central Leptin and Cytokine Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|3|3|189-199

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.3, Iss.3, 2003-09, pp. : 189-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Genetics of Obesity and the Metabolic Syndrome

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 2, 2010-06 ,pp. : 86-108

Bentham Science Publishers

Access to resources Recommend Favorite

Global Life-Long Health Benefits of Repression of Hypothalamic NPY System by Central Leptin Gene Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 17, 2007-09 ,pp. : 1675-1681

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 15, Iss. 29, 2009-10 ,pp. : 3446-3462

Bentham Science Publishers

Access to resources Recommend Favorite

Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome

By  

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5267-5280

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 895-903

Bentham Science Publishers

Access to resources Recommend Favorite